NDC 63323-651-01 - ADENOSINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-651
- Requested NDC
- 63323-651-01
- Package NDCs from labels
- 63323-651-00, 63323-651-02, 63323-651-01, 63323-651-04, 63323-651-20, 63323-651-30, 63323-651-21, 63323-651-89, 63323-651-23, 63323-651-90
- Manufacturer
- Henry Schein, Inc.
- Effective date
- 2025-10-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| adenosine injection, solution - Henry Schein, Inc. | Henry Schein, Inc. | 2025-10-27 | HUMAN PRESCRIPTION DRUG LABEL |
| ADENOSINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-05-09 | HUMAN PRESCRIPTION DRUG LABEL |
| ADENOSINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2023-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
| ADENOSINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2023-06-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Adenosine - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-04-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Adenosine - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-03-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Adenosine Injection USP | REMEDYREPACK INC. | 2020-04-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Adenosine - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | 2018-12-04 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-651-00 | Adenosine | 2 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 2 | 4 | |
| 63323-651-01 | Adenosine | 4 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 4 | 4 | |
| 63323-651-02 | Adenosine | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 4 | |
| 63323-651-04 | Adenosine | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 4 | |
| 63323-651-20 | Adenosine | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 3 | |
| 63323-651-20 | Adenosine | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 3 | |
| 63323-651-30 | Adenosine | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 3 | |
| 63323-651-30 | Adenosine | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 3 | |
| 63323-651-21 | Adenosine | 2 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 2 | 1 | |
| 63323-651-23 | Adenosine | 4 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 4 | 1 | |
| 63323-651-89 | Adenosine | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 1 | |
| 63323-651-90 | Adenosine | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-651 | ADENOSINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 4 | Current NDC, Legacy NDC, 4 package rows | 20230830_e660f71c-35ed-438e-8505-4538f5e925a2.zip |
| 63323-651 | ADENOSINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | Current NDC, Legacy NDC, 4 package rows | 20230406_f88a8cf7-d354-42f2-b5e8-ba002fcfc460.zip |
| 63323-651 | ADENOSINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | Current NDC, Legacy NDC, 4 package rows | 20190328_6785cf30-360f-409b-a4b2-fc910728f01f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-651-00 | ML - Milliliter | 63323-651 | e973a2d1-989f-491d-a079-52aafba7ffff | 1 | 2024-06-10 |
| 63323-651-01 | ML - Milliliter | 63323-651 | 1bac6cc0-c696-47d2-983e-f5f0324be57c | 1 | 2024-09-09 |
| 63323-651-02 | ML - Milliliter | 63323-651 | 78983a12-3bfa-4b89-bdbb-da5fed8cabfa | 1 | 2012-07-24 |
| 63323-651-04 | ML - Milliliter | 63323-651 | 3a1f0bc2-e05e-4e83-aa3e-f674a66b447a | 1 | 2012-07-24 |
| 63323-651-20 | ML - Milliliter | 63323-651 | cf3c7cc6-ed97-4cba-8923-3d3ad265245f | 1 | 2018-06-11 |
| 63323-651-21 | ML - Milliliter | 63323-651 | e457f5a3-0292-4515-b4e1-9211cfa48312 | 1 | 2019-04-11 |
| 63323-651-23 | ML - Milliliter | 63323-651 | fd358bc0-e9b9-4b9d-ae64-5fd92d987f7e | 1 | 2019-04-11 |
| 63323-651-30 | ML - Milliliter | 63323-651 | 847bb02f-e73c-4e81-9cb2-8fa5cd9565b0 | 1 | 2018-06-11 |
| 63323-651-89 | ML - Milliliter | 63323-651 | 2aab18ab-f841-43da-8c3f-46ba9dbbe611 | 1 | 2019-04-11 |
| 63323-651-90 | ML - Milliliter | 63323-651 | 9644624d-c0c1-4f8a-af80-b04327c95dca | 1 | 2019-04-11 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ADENOSINE | ACTIVE INGREDIENT | K72T3FS567 | ADENOSINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| ADENOSINE | ACTIVE MOIETY | K72T3FS567 | ADENOSINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | ADENOSINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hypertonic Saline Solution Sodium Chloride | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 750ea4b1-de2b-4299-aaa2-331daf383d0d | 2026-07-30 | Warnings | 451W47IQ8X |
| DECONIMO Reconstitution | DECONIMO RECONSTITUTION | Image Amazon LLC | 57ab9b1c-9a18-3786-e063-6394a90a2c63 | 2026-07-28 | Warnings | 059QF0KO0R |
| Delflex | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | a98facd6-9daa-4d37-8209-63a0599dbfaa | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | 9a1220fb-6853-45ae-838c-10d8596e1af7 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | af5cdf1a-19f4-11e2-892e-0800200c9a66 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Adenosine | ADENOSINE | Sagent Pharmaceuticals | 546642f2-662f-46cf-9d82-5bb3bdcc7677 | 2026-07-27 | Warnings, Adverse reactions | 1654169 K72T3FS567 |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 19daf830-7270-4661-81b1-ded38f867f28 | 2026-07-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Sterile Water | WATER | Cardinal Health 107, LLC | 9655cd02-82b5-4a75-813b-854b19551481 | 2026-07-21 | Warnings, Adverse reactions | 059QF0KO0R |
| Whisidom Saline Solution | SODIUM CHLORIDE 0.9% SALINE SOLUTION | Jiangxi Yudexi Pharmaceutical Co., LTD | 4e4e4169-2a14-3466-e063-6394a90a081b | 2026-07-20 | Warnings | 451W47IQ8X |
| Saline | NASAL | BEST CHOICE (VALU MERCHANDISERS COMPANY) | 71485e82-bf54-4b8b-8dd2-2a0761534520 | 2026-07-17 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-07-15 | Warnings, Adverse reactions | 451W47IQ8X |
| WHWSWB 0.9% SALINE | SODIUM CHLORIDE | Yiwu Huanshu E-commerce Co., Ltd | 5082b773-79b2-2501-e063-6394a90a170f | 2026-07-11 | Warnings | 451W47IQ8X |
| SALINE NASAL | SODIUM CHLORIDE | ALAINA HEALTHCARE PRIVATE LIMITED | ed30a7f9-7132-42da-9bed-63a9b1c80ab2 | 2026-07-07 | Warnings | 451W47IQ8X |
| Dr. Drop NMN Vital Balance (Drop No.1 Cream 90g) | NMN (NICOTINAMIDE MONONUCLEOTIDE), ECTOIN (ECTOINE) | Reedfresh Co., LTD | 55d703ca-ff9d-0dbc-e063-6294a90ab6b1 | 2026-07-05 | Warnings | 059QF0KO0R |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Protective Industrial Products, Inc. | 558e5926-9027-d3f6-e063-6294a90ab121 | 2026-07-02 | Warnings | 059QF0KO0R |
| Fendall 2000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a1d07e-0006-0c75-e063-6394a90a7acc | 2026-07-02 | Warnings | 059QF0KO0R |
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-07-02 | Warnings | 059QF0KO0R |
| Sterile Eyesaline Eyewash | STERILE EYESALINE EYEWASH | Protective Industrial Products, Inc. | 55a290e8-8310-8be4-e063-6394a90abdce | 2026-07-02 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Protective Industrial Products, Inc. | 55a261c2-725d-6765-e063-6294a90a3260 | 2026-07-02 | Warnings | 059QF0KO0R |
| Remodulin | TREPROSTINIL | United Therapeutics Corporation | 6c80bb38-e8db-4138-9f0d-dbbf9c673185 | 2026-07-02 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.